Assessing Multiple Treatment Regimens for Tuberculosis
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: New England Journal of Medicine
Authors: Hanif Esmail, Nicholas I. Paton, Jodie A. Schildkraut, Ilaria Motta, Alexander J. Szubert, Suzanne M. Dufault, Norbert Heinrich, Simon Tiberi, Cissy M. Kityo, Timothy D. McHugh, Fairoez Ryklief, Daniela M. Cirillo, Rodney Dawson, Karen Sanders, Stellah Mpagama, Lindsay C. Thompson, Le Hong Van, Dominic Wakerley, Elena Tudor, Angela M. Crook, Patrick P.J. Phillips, Guy Thwaites, Christoph Lange, Martin J. Boeree, Gareth Maher-Edwards, Natasa Lazarevic, Jolanda E. van de Logt, Derek J. Sloan, David Barros-Aguirre, Michael Hoelscher
Institutions: University College London, National University of Singapore, London School of Hygiene & Tropical Medicine, Radboud University Medical Center, University of California, San Francisco, LMU Klinikum, Fraunhofer Institute for Translational Medicine and Pharmacology, German Center for Infection Research, Institut für Infektions- und Tropenmedizin, Ludwig-Maximilians-Universität München, Queen Mary University of London, Blizard Institute, Joint Clinical Research Centre, IRCCS Ospedale San Raffaele, University of Cape Town, Kilimanjaro Clinical Research Institute, Oxford University Clinical Research Unit, Phthisiopneumology Institute "Chiril Draganiuc", University of Oxford, Baylor College of Medicine, Research Center Borstel - Leibniz Lung Center, Texas Children's Hospital, University of Lübeck, Otsuka (Germany), Johnson & Johnson (Netherlands), University of St Andrews, GlaxoSmithKline (Spain), Helmholtz Munich
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Innovative Health Initiative
OpenAlex ID: W7236784751
